Browsing Tag
Eydenzelt
2 posts
Can Celltrion’s Eydenzelt disrupt Canada’s aflibercept market after Health Canada approval?
Celltrion secures Health Canada approval for Eydenzelt, its aflibercept biosimilar. Explore how it aims to disrupt Canada’s high-cost eye care drug market.
Celltrion’s Eydenzelt gets FDA nod — Is Eylea finally facing a real biosimilar rival?
Find out how Celltrion’s FDA-approved Eydenzelt is set to challenge Eylea and reshape the biosimilar landscape for retinal diseases in 2025.